Amyloid-β and Astrocytes Interplay in Amyloid-β Related Disorders

doi:10.3390/ijms17030338

Review

. 2016 Mar 4;17(3):338.

doi: 10.3390/ijms17030338.

Amyloid-β and Astrocytes Interplay in Amyloid-β Related Disorders

Yazan S Batarseh¹, Quoc-Viet Duong², Youssef M Mousa³, Sweilem B Al Rihani⁴, Khaled Elfakhri⁵, Amal Kaddoumi⁶

Affiliations

¹ Department of Basic Pharmaceutical Sciences, School of Pharmacy, University of Louisiana at Monroe, Monroe, LA 70504, USA. batarsy@warhawks.ulm.edu.
² Department of Basic Pharmaceutical Sciences, School of Pharmacy, University of Louisiana at Monroe, Monroe, LA 70504, USA. duongqa@warhawks.ulm.edu.
³ Department of Basic Pharmaceutical Sciences, School of Pharmacy, University of Louisiana at Monroe, Monroe, LA 70504, USA. mousaym@warhawks.ulm.edu.
⁴ Department of Basic Pharmaceutical Sciences, School of Pharmacy, University of Louisiana at Monroe, Monroe, LA 70504, USA. alrihasb@warhawks.ulm.edu.
⁵ Department of Basic Pharmaceutical Sciences, School of Pharmacy, University of Louisiana at Monroe, Monroe, LA 70504, USA. hamadgh@warhawks.ulm.edu.
⁶ Department of Basic Pharmaceutical Sciences, School of Pharmacy, University of Louisiana at Monroe, Monroe, LA 70504, USA. kaddoumi@ulm.edu.

PMID: 26959008
PMCID: PMC4813200
DOI: 10.3390/ijms17030338

Review

Amyloid-β and Astrocytes Interplay in Amyloid-β Related Disorders

Yazan S Batarseh et al. Int J Mol Sci. 2016.

. 2016 Mar 4;17(3):338.

doi: 10.3390/ijms17030338.

Authors

Yazan S Batarseh¹, Quoc-Viet Duong², Youssef M Mousa³, Sweilem B Al Rihani⁴, Khaled Elfakhri⁵, Amal Kaddoumi⁶

Affiliations

¹ Department of Basic Pharmaceutical Sciences, School of Pharmacy, University of Louisiana at Monroe, Monroe, LA 70504, USA. batarsy@warhawks.ulm.edu.
² Department of Basic Pharmaceutical Sciences, School of Pharmacy, University of Louisiana at Monroe, Monroe, LA 70504, USA. duongqa@warhawks.ulm.edu.
³ Department of Basic Pharmaceutical Sciences, School of Pharmacy, University of Louisiana at Monroe, Monroe, LA 70504, USA. mousaym@warhawks.ulm.edu.
⁴ Department of Basic Pharmaceutical Sciences, School of Pharmacy, University of Louisiana at Monroe, Monroe, LA 70504, USA. alrihasb@warhawks.ulm.edu.
⁵ Department of Basic Pharmaceutical Sciences, School of Pharmacy, University of Louisiana at Monroe, Monroe, LA 70504, USA. hamadgh@warhawks.ulm.edu.
⁶ Department of Basic Pharmaceutical Sciences, School of Pharmacy, University of Louisiana at Monroe, Monroe, LA 70504, USA. kaddoumi@ulm.edu.

PMID: 26959008
PMCID: PMC4813200
DOI: 10.3390/ijms17030338

Abstract

Amyloid-β (Aβ) pathology is known to promote chronic inflammatory responses in the brain. It was thought previously that Aβ is only associated with Alzheimer's disease and Down syndrome. However, studies have shown its involvement in many other neurological disorders. The role of astrocytes in handling the excess levels of Aβ has been highlighted in the literature. Astrocytes have a distinctive function in both neuronal support and protection, thus its involvement in Aβ pathological process may tip the balance toward chronic inflammation and neuronal death. In this review we describe the involvement of astrocytes in Aβ related disorders including Alzheimer's disease, Down syndrome, cerebral amyloid angiopathy, and frontotemporal dementia.

Keywords: Alzheimer’s disease; Amyloid-β; Down syndrome; astrocytes; cerebral amyloid angiopathy; frontotemporal dementia.

PubMed Disclaimer

Cited by

Telmisartan Modulates Glial Activation: In Vitro and In Vivo Studies.
Torika N, Asraf K, Danon A, Apte RN, Fleisher-Berkovich S. Torika N, et al. PLoS One. 2016 May 17;11(5):e0155823. doi: 10.1371/journal.pone.0155823. eCollection 2016. PLoS One. 2016. PMID: 27187688 Free PMC article.
Comparison of the Protective Effects of Ginsenosides Rb1 and Rg1 on Improving Cognitive Deficits in SAMP8 Mice Based on Anti-Neuroinflammation Mechanism.
Yang Y, Li S, Huang H, Lv J, Chen S, Pires Dias AC, Li Y, Liu X, Wang Q. Yang Y, et al. Front Pharmacol. 2020 Jun 10;11:834. doi: 10.3389/fphar.2020.00834. eCollection 2020. Front Pharmacol. 2020. PMID: 32587516 Free PMC article.
Yishen Huazhuo decoction regulates microglial polarization to reduce Alzheimer's disease-related neuroinflammation through TREM2.
Wang K, Zan S, Xu J, Sun W, Li C, Zhang W, Ni D, Cheng R, Li L, Yu Z, Zhang L, Liu S, Cui Y, Zhang Y. Wang K, et al. Heliyon. 2024 Aug 6;10(16):e35800. doi: 10.1016/j.heliyon.2024.e35800. eCollection 2024 Aug 30. Heliyon. 2024. PMID: 39220981 Free PMC article.
NGF and the Amyloid Precursor Protein in Alzheimer's Disease: From Molecular Players to Neuronal Circuits.
Triaca V, Ruberti F, Canu N. Triaca V, et al. Adv Exp Med Biol. 2021;1331:145-165. doi: 10.1007/978-3-030-74046-7_10. Adv Exp Med Biol. 2021. PMID: 34453297 Review.
The neuroprotective N-terminal amyloid-β core hexapeptide reverses reactive gliosis and gliotoxicity in Alzheimer's disease pathology models.
Lantz MJ, Roberts AM, Delgado DD, Nichols RA. Lantz MJ, et al. J Neuroinflammation. 2023 May 27;20(1):129. doi: 10.1186/s12974-023-02807-9. J Neuroinflammation. 2023. PMID: 37245024 Free PMC article.

See all "Cited by" articles

References

1. Glenner G.G., Wong C.W. Alzheimer’s disease and down’s syndrome: Sharing of a unique cerebrovascular amyloid fibril protein. Biochem. Biophys. Res. Commun. 1984;122:1131–1135. doi: 10.1016/0006-291X(84)91209-9. - DOI - PubMed
1. Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., Beyreuther K. Amyloid plaque core protein in Alzheimer disease and down syndrome. Proc. Natl. Acad. Sci. USA. 1985;82:4245–4249. doi: 10.1073/pnas.82.12.4245. - DOI - PMC - PubMed
1. Selkoe D.J. Alzheimer’s disease: Genes, proteins, and therapy. Physiol. Rev. 2001;81:741–766. doi: 10.1101/cshperspect.a004457. - DOI - PubMed
1. Kacem K., Lacombe P., Seylaz J., Bonvento G. Structural organization of the perivascular astrocyte endfeet and their relationship with the endothelial glucose transporter: A confocal microscopy study. Glia. 1998;23:1–10. doi: 10.1002/(SICI)1098-1136(199805)23:1<1::AID-GLIA1>3.0.CO;2-B. - DOI - PubMed
1. Abbott N.J. Astrocyte-endothelial interactions and blood-brain barrier permeability. J. Anat. 2002;200:629–638. doi: 10.1046/j.1469-7580.2002.00064.x. - DOI - PMC - PubMed

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

[1] Glenner G.G., Wong C.W. Alzheimer’s disease and down’s syndrome: Sharing of a unique cerebrovascular amyloid fibril protein. Biochem. Biophys. Res. Commun. 1984;122:1131–1135. doi: 10.1016/0006-291X(84)91209-9. - DOI - PubMed

[2] Glenner G.G., Wong C.W. Alzheimer’s disease and down’s syndrome: Sharing of a unique cerebrovascular amyloid fibril protein. Biochem. Biophys. Res. Commun. 1984;122:1131–1135. doi: 10.1016/0006-291X(84)91209-9. - DOI - PubMed

[3] Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., Beyreuther K. Amyloid plaque core protein in Alzheimer disease and down syndrome. Proc. Natl. Acad. Sci. USA. 1985;82:4245–4249. doi: 10.1073/pnas.82.12.4245. - DOI - PMC - PubMed

[4] Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., Beyreuther K. Amyloid plaque core protein in Alzheimer disease and down syndrome. Proc. Natl. Acad. Sci. USA. 1985;82:4245–4249. doi: 10.1073/pnas.82.12.4245. - DOI - PMC - PubMed

[5] Selkoe D.J. Alzheimer’s disease: Genes, proteins, and therapy. Physiol. Rev. 2001;81:741–766. doi: 10.1101/cshperspect.a004457. - DOI - PubMed

[6] Selkoe D.J. Alzheimer’s disease: Genes, proteins, and therapy. Physiol. Rev. 2001;81:741–766. doi: 10.1101/cshperspect.a004457. - DOI - PubMed

[7] Kacem K., Lacombe P., Seylaz J., Bonvento G. Structural organization of the perivascular astrocyte endfeet and their relationship with the endothelial glucose transporter: A confocal microscopy study. Glia. 1998;23:1–10. doi: 10.1002/(SICI)1098-1136(199805)23:1<1::AID-GLIA1>3.0.CO;2-B. - DOI - PubMed

[8] Kacem K., Lacombe P., Seylaz J., Bonvento G. Structural organization of the perivascular astrocyte endfeet and their relationship with the endothelial glucose transporter: A confocal microscopy study. Glia. 1998;23:1–10. doi: 10.1002/(SICI)1098-1136(199805)23:1<1::AID-GLIA1>3.0.CO;2-B. - DOI - PubMed

[9] Abbott N.J. Astrocyte-endothelial interactions and blood-brain barrier permeability. J. Anat. 2002;200:629–638. doi: 10.1046/j.1469-7580.2002.00064.x. - DOI - PMC - PubMed

[10] Abbott N.J. Astrocyte-endothelial interactions and blood-brain barrier permeability. J. Anat. 2002;200:629–638. doi: 10.1046/j.1469-7580.2002.00064.x. - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Amyloid-β and Astrocytes Interplay in Amyloid-β Related Disorders

Affiliations

Amyloid-β and Astrocytes Interplay in Amyloid-β Related Disorders

Authors

Affiliations

Abstract

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Abstract

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical